CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.3B
1-Year Est. Return 45.9%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$148M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
516
New
Increased
Reduced
Closed

Top Buys

1
+$6.89M
2
+$4.05M
3
+$4M
4
FUTU icon
Futu Holdings
FUTU
+$3.28M
5
AVGO icon
Broadcom
AVGO
+$3.25M

Top Sells

1
+$2.28M
2
+$2.13M
3
+$2.05M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.05M
5
TMUS icon
T-Mobile US
TMUS
+$2.03M

Sector Composition

1 Technology 39.61%
2 Healthcare 20.82%
3 Communication Services 12.95%
4 Consumer Discretionary 11.61%
5 Consumer Staples 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INBX icon
401
Inhibrx
INBX
$853M
$85.5K 0.01%
2,539
-368
RGNX icon
402
Regenxbio
RGNX
$401M
$85.4K 0.01%
8,854
-1,221
SLDB icon
403
Solid Biosciences
SLDB
$700M
$84.2K 0.01%
13,649
-1,920
CYD icon
404
China Yuchai International
CYD
$1.4B
$82.7K 0.01%
+2,000
ABSI icon
405
Absci
ABSI
$425M
$79.7K 0.01%
26,209
+589
PHVS icon
406
Pharvaris
PHVS
$1.78B
$74.8K 0.01%
+3,000
MRVI icon
407
Maravai LifeSciences
MRVI
$419M
$72.8K 0.01%
25,360
-3,557
ATEC icon
408
Alphatec Holdings
ATEC
$1.65B
$72.7K 0.01%
+5,000
ATXS
409
DELISTED
Astria Therapeutics
ATXS
$72K 0.01%
9,892
-1,443
FDMT icon
410
4D Molecular Therapeutics
FDMT
$476M
$71.1K 0.01%
8,186
-1,118
EOLS icon
411
Evolus
EOLS
$261M
$69.6K 0.01%
11,338
-1,612
ALMS
412
Alumis Inc
ALMS
$3.15B
$67.8K 0.01%
16,982
-2,215
PACB icon
413
Pacific Biosciences
PACB
$381M
$67.4K 0.01%
52,650
-9,540
AURA icon
414
Aura Biosciences
AURA
$398M
$67.3K 0.01%
10,889
-1,564
LXEO icon
415
Lexeo Therapeutics
LXEO
$399M
$62.9K 0.01%
9,466
+2,799
BCYC
416
Bicycle Therapeutics
BCYC
$300M
$62.7K 0.01%
8,104
-762
RCKT icon
417
Rocket Pharmaceuticals
RCKT
$409M
$61.7K 0.01%
18,914
-2,725
CGEM icon
418
Cullinan Oncology
CGEM
$778M
$61.4K 0.01%
10,355
-1,498
ALT icon
419
Altimmune
ALT
$393M
$58.3K ﹤0.01%
15,470
-820
TKNO icon
420
Alpha Teknova
TKNO
$145M
$58.1K ﹤0.01%
9,380
-1,353
BBOT
421
BridgeBio Oncology
BBOT
$711M
$57.9K ﹤0.01%
+5,000
AMRN
422
Amarin Corp
AMRN
$301M
$57.9K ﹤0.01%
3,534
-487
REPL icon
423
Replimune Group
REPL
$596M
$57.3K ﹤0.01%
13,682
-1,801
AUTL
424
Autolus Therapeutics
AUTL
$322M
$57.3K ﹤0.01%
35,157
-5,116
EDIT icon
425
Editas Medicine
EDIT
$218M
$54.7K ﹤0.01%
15,762
-1,051
15 16
17
18 19